Global Swabs And Viral Transport Media Market Overview
Viral transport medium is a transport system that enables the safe transfer of viruses, chlamydia, mycoplasma, or ureaplasma organisms. The swab is a sample collected from the infected patient’s body and later sent to laboratories in the transport medium. The vital transport medium segment is projected to grow at a high CAGR throughout the estimated timeframe. The rise in the need and demand for the detection and prevention of infectious diseases across the globe is augmenting the growth of the market. The global swabs and viral transport media market accounted for 2.6 billion in 2020 and is estimated to be US$ 3.8 billion by 2029 and is anticipated to register a CAGR of 4.4%.
COVID-19 Impact on the Market:
The demand for swabs and viral transport media has increased multifold due to the current pandemic condition. The demand for swabs and viral transport media is so high that many manufacturers have surged their production capacities to develop products useful for viral collection, maintenance, and culture. Furthermore, increasing investments by prominent players and other industries has created growth opportunities for the target market. This report will quantify the impact of this pandemic on the swabs and viral transport media market.
Global Swabs And Viral Transport Media Market Dynamics
Growth in government initiatives for infectious and non-infectious diseases
The need to address patients' health has become a priority for government organizations and healthcare providers across the globe. In addition, the U.S. Administration for Community Living, Department of Health and Human Services, provides sponsorship for various studies on sepsis. Moreover, the development of new therapies for the treatment of infectious diseases has been encouraged by these initiatives offered by the government. Further, FDA eases rules on viral transport media to increase availability for COVID-19 testing. Thus, driving growth of the target market.
A growing number of patients infected with coronavirus
The demand for a swab and viral transport media has fueled during this ongoing coronavirus crisis because of rapid antigen testing and molecular assay experiments. Direct fluorescent antibody (DVA) and long-term freezer applications are creating lucrative growth opportunities for companies in the global swab and viral transport media market.
However, the issues regarding false negatives and reinfection might hamper the growth of the global market.
Global Swabs And Viral Transport Media Market Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The global swabs and viral transport media market is segmented based on the product type, indication, end-user, and region.
Depending upon the product type, the global business is categorized into virus swabs (nasopharyngeal swabs, deep nasal swabs, combined nasal & throat swabs, culture swabs, and vaginal swabs) and viral transport medium (tissue culture medium and glycerol transport medium). In terms of indication, the worldwide industry is categorized into influenza, respiratory syncytial virus, mumps virus, adenovirus, rhinovirus, herpes simplex virus, varicella-zoster virus, and other indication. Based on the end-user, the target market is segmented into diagnostic laboratories, hospital & ASC’s, specialty clinics, and others.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America swab and VTM market accounted for a significant share in 2019. Growing awareness about the benefits of disease prevention and an increase in healthcare expenditure boosts the swab and VTM market in North America. In addition, the presence of prominent companies and growth strategies undertaken by them are creating a positive impact on the growth of the target market. Furthermore, Asia Pacific accounted for the second-highest share of the global swab and VTM market in 2019, owing to the rise in the prevalence of infectious diseases. Factors such as a rise in awareness regarding routine check-up and diagnosis along with the development of vaccines and other pharma products to fight against diseases are influencing the growth of the global market in the Asia Pacific.
Report Scope:
|
Attribute |
Details |
|
The base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Product Type - Virus Swabs (Nasopharyngeal Swabs, Deep Nasal Swabs, Combined Nasal & Throat Swabs, Culture Swabs, and Vaginal Swabs) and Viral Transport Medium (Tissue Culture Medium and Glycerol Transport Medium) By Indication - Influenza, Respiratory syncytial virus, Mumps Virus, Adenovirus, Rhinovirus, Herpes Simplex Virus, Varicella-Zoster Virus, and Other Indication By End-user - Diagnostic Laboratories, Hospital & ASC’s, Specialty Clinics, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029. For the purpose of this study, has segmented the global swabs and viral transport media market report based on product type, indication, end-user, and region.
Global Swabs and Viral Transport Media Market, By Product Type:
- Virus Swabs
- Nasopharyngeal Swabs
- Deep Nasal Swabs
- Combined Nasal & Throat Swabs
- Culture Swabs
- Vaginal Swabs
- Viral Transport Medium
- Tissue Culture Medium
- Glycerol Transport Medium
Global Swabs and Viral Transport Media Market, By Indication:
- Influenza
- Respiratory syncytial virus
- Mumps Virus
- Adenovirus
- Rhinovirus
- Herpes Simplex Virus
- Varicella-Zoster Virus
- Other Indication
Global Swabs and Viral Transport Media Market, By End-user:
- Diagnostic Laboratories
- Hospital & ASC’s
- Specialty Clinics
- Others
Global Swabs and Viral Transport Media Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Swabs And Viral Transport Media Market Key Players
The key players operating in the global swabs and viral transport media market include Thermo Fisher Scientific Inc., Laboratory Corporation of America, Puritan Medical Products, Lucence Diagnostics Pte Ltd, Becton, Dickinson and Company, BTNX, Formlabs, Medline Industries, Inc., VIRCELL S.L., HiMedia Laboratories, Hardy Diagnostics, and Titan Biotech Ltd. Development of new products useful for viral collection, maintenance, and culture are key strategies adopted by the market players. For instance, in July 2020, Global Marketing Services (GMS) launched the first locally produced viral transport medium for cost-efficient highest quality sample collection solution to combat with COVID-19.
Global Swabs And Viral Transport Media Market Company Profile
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Type Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Laboratory Corporation of America
- Puritan Medical Products
- Lucence Diagnostics Pte Ltd.
- Becton, Dickinson and Company
- BTNX
- Formlabs
- Medline Industries, Inc.
- VIRCELL S.L.
- HiMedia Laboratories
- Hardy Diagnostics
- Titan Biotech Ltd.
“*” marked represents similar segmentation in other categories in the respective section
Global Swabs And Viral Transport Media Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Swabs and Viral Transport Media Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Swabs and Viral Transport Media Market, By Product Type, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Virus Swabs
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Nasopharyngeal Swabs
- Deep Nasal Swabs
- Combined Nasal & Throat Swabs
- Culture Swabs
- Vaginal Swabs
- Viral Transport Medium
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Tissue Culture Medium
- Glycerol Transport Medium
- Overview
- Global Swabs and Viral Transport Media Market, By Indication, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Influenza
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Respiratory syncytial virus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Mumps Virus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Adenovirus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Rhinovirus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Herpes Simplex Virus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Varicella-Zoster Virus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Other Indication
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Swabs and Viral Transport Media Market, By End-user, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Diagnostic Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Hospital & ASC’s
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Specialty Clinics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Swabs and Viral Transport Media Market, By Region, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Indication, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Indication, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Indication, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Indication, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Indication, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Type Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Puritan Medical Products
- Laboratory Corporation of America
- Lucence Diagnostics Pte Ltd.
- Becton, Dickinson and Company
- BTNX
- Formlabs
- Medline Industries, Inc.
- VIRCELL S.L.
- HiMedia Laboratories
- Hardy Diagnostics
- Titan Biotech Ltd.
- Thermo Fisher Scientific, Inc.
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The swabs and viral transport media market accounted for 2.6 billion in 2020 and is estimated to be US$ 3.8 billion by 2029 and is anticipated to register a CAGR of 4.4%.
The market report has been segmented on the basis of product type, indication, end-user, and region.
Emerging trends include the development of innovative swab materials, the increasing demand for viral transport media for diagnostic testing, and the growth of home-based and point-of-care testing, presenting significant opportunities in the global Swabs and Viral Transport Media Market.
Factors driving the market include the global focus on diagnostic testing for infectious diseases, the need for effective sample collection and transportation, advancements in swab and transport media technologies, and the ongoing efforts to combat infectious disease outbreaks.
The report covers regions worldwide. North America is expected to dominate the Swabs and Viral Transport Media Market, driven by a well-established healthcare infrastructure, high testing volumes, and significant investments in diagnostic technologies in the region. Other influential regions include Europe and Asia-Pacific.
The prominent player operating in the global swabs and viral transport media market includes Thermo Fisher Scientific Inc., Laboratory Corporation of America, Puritan Medical Products, Lucence Diagnostics Pte Ltd, Becton, Dickinson and Company, BTNX, Formlabs, Medline Industries, Inc., VIRCELL S.L., HiMedia Laboratories, Hardy Diagnostics, and Titan Biotech Ltd.